The effect of high dose intravenous immunoglobulin (IVIg) treatment was studied in six patients with multifocal motor neuropathy (MMN 
Patients with clinical signs of progressive asymmetric weakness and muscle wasting without sensory loss usually have motor neuron disease; however, when electroneurophysiological examination shows motor conduction block, multifocal motor neuropathy (MMN) should be considered.' 6 Patients with MMN may respond to immunosuppressive treatment,2 by contrast with those with motor neuron disease.7 A beneficial effect of high dose intravenous immunoglobulin (IVIg), which has few serious side effects, has also been reported in these patients.4 6 The aim of our study was Conduction studies were performed with standard techniques of supramaximal percutaneous stimulation and surface electrode recording (Dantec Counterpoint or Nicolet Viking apparatus). During all recordings, skin temperature was maintained at 34°C with an infrared heat lamp. Motor conduction studies were performed in ulnar, median, and peroneal nerves. The ulnar and median nerves were stimulated at the axilla, at the elbow (median nerve), above and below the elbow (ulnar nerve), and at the wrist. The peroneal nerve was stimulated above and below the fibular head and at the ankle. F responses were recorded in a series of 20 
